Analyst Ratings February 24, 2026

Citizens Boosts Affirm Price Target to $105, Citing Scale and Margin Parity with Discover

Analyst firm models five-year GMV-led expansion and adds value for tax assets to reach a higher valuation

By Priya Menon AFRM
Citizens Boosts Affirm Price Target to $105, Citing Scale and Margin Parity with Discover
AFRM

Citizens raised its price objective on Affirm Holdings Inc. to $105 while keeping a Market Outperform rating, citing projected gross merchandise volume growth and an eventual net margin profile similar to Discover Financial Services. The new target, based on a five-year forecast through fiscal 2030 and a series of valuation assumptions, implies roughly 123% upside from the stock's recent price of $47.13.

Key Points

  • Citizens raised Affirm's price target to $105, maintaining a Market Outperform rating and implying about 123% upside from the $47.13 share price.
  • The valuation is based on a five-year forecast through fiscal 2030, with GMV growth assumptions and take-rate/net-margin assumptions modeled similar to Discover Financial Services.
  • Affirm's fiscal Q2 revenue of $1.12 billion, up 30% year-over-year, outpaced a Stephens estimate of $1.05 billion; other firms have adjusted targets and ratings in response to results.

Citizens has increased its price target for Affirm Holdings Inc. to $105.00 from an undisclosed previous level and maintained a Market Outperform rating on the shares. The firm says the new target implies approximately 123% upside from Affirm's current market price of $47.13, which is down about 41% over the past six months.

In its analysis, Citizens argues that Affirm can reach sufficient operating scale across the coming years driven by growth in gross merchandise volume (GMV). The firm projects that Affirm's net margin profile will eventually mirror that of Discover Financial Services, a comparison Citizens used when setting take-rate and net-margin assumptions for its model. Citizens noted Affirm's recent revenue growth of 33% as supportive evidence for the expansion thesis, citing InvestingPro data.

The $105 target is the outcome of a five-year projection that runs through fiscal 2030. Citizens applied specific GMV growth assumptions across that horizon and used a take rate and net margin aligned with Discover Financial Services to estimate future profitability. Projected earnings were then discounted and Citizens applied a growth-oriented price-to-earnings multiple of about 25 times to derive a $102 price target before additional adjustments.

Citizens then added $3 per share to reflect the value of Affirm's net operating loss carryforwards, which the firm values at roughly $1 billion in aggregate. The combined adjustments bring Citizens' valuation to $105 per share. On the basis of Citizens' internal estimates, that $105 figure corresponds to about 28 times the firm’s estimate of Affirm's adjusted operating income in 2027.

Citizens also highlighted Affirm's current trading multiples. The stock is trading at a price/earnings-to-growth (PEG) ratio near 0.26, which Citizens and InvestingPro interpret as the shares being attractively valued relative to the company's growth prospects.

Recent company results and peer analyst moves provide additional context. Affirm reported fiscal second-quarter revenue of $1.12 billion, a 30% year-over-year increase, topping Stephens' revenue estimate of $1.05 billion. Following those results, Stephens lowered its price target for Affirm to $65 from $75, citing peer multiple compression. By contrast, Compass Point increased its price target to $68 from $64 and maintained a Buy rating based on what it described as strong execution and projected adjusted earnings per share. Goldman Sachs reiterated a Buy rating with an $83 price objective, pointing to Affirm's solid financial results and the firm's typical "beat and raise" outcome despite prevailing market headwinds.

Beyond earnings and analyst revisions, Citizens' note and other reports reference strategic business developments. Affirm announced a partnership with Lowe's to provide flexible payment plans that let customers split purchases into biweekly or monthly payments. The offering includes payment plans starting at 0% APR for eligible customers and emphasizes real-time eligibility determinations and transparent costs.

Market reactions have been mixed across related fintech names. Affirm and Block stocks initially declined on investor concerns about artificial intelligence disruption but trimmed losses later amid reports of acquisition interest in PayPal, which itself had seen a notable stock decline.


Summary

Citizens raised its price target on Affirm to $105, based on a five-year forecast that assumes strong GMV growth and eventual margin parity with Discover Financial Services, adding $3 per share for NOLs and applying a growth-oriented 25x P/E multiple. The target implies about 123% upside from a recent share price of $47.13.

Key points

  • Citizens set a $105 target and kept a Market Outperform rating, implying 123% upside from the current $47.13 share price.
  • The valuation is built on a five-year GMV-led growth forecast to fiscal 2030 with take-rate and net margin assumptions similar to Discover Financial Services.
  • Affirm reported fiscal Q2 revenue of $1.12 billion, up 30% year-over-year, and several firms have adjusted price targets and ratings in response to the results.

Risks and uncertainties

  • Peer multiple compression: Stephens lowered its price target citing pressure on comparable company multiples, which could affect Affirm's market valuation - relevant to the financials and equity markets sectors.
  • Market sensitivity: Affirm and related fintech stocks have shown susceptibility to thematic concerns such as AI disruption, creating volatility risks in fintech and payments sectors.

Risks

  • Peer multiple compression has prompted at least one analyst to lower a price target, which could apply downward pressure across fintech valuations and affect investor sentiment.
  • Sector volatility tied to thematic concerns such as artificial intelligence disruption has contributed to share price swings for Affirm and related fintech firms.

More from Analyst Ratings

Raymond James Elevates Vir Biotechnology After VIR-5500 Data, Raises Price Target to $19 Feb 24, 2026 Canaccord Lifts Kratos Defense Target After Robust FY2025 Results Feb 24, 2026 Evercore ISI Lifts Vir Biotechnology Price Target After Astellas Partnership and Phase 1 Readout Feb 24, 2026 Raymond James Sees Nvidia Near Intermediate-Term Low as Buying Interest Rises Feb 24, 2026 D.A. Davidson Keeps Buy on Nvidia, Sees Share Price Priced for a 2026 AI Peak Feb 24, 2026